Bai, Wanjun <br/><br/>
Prostaglandin E1 dose-dependently promotes stability of atherosclerotic plaque in a rabbit model.  [electronic resource] 

 -  Canadian journal of physiology and pharmacology  Feb 2012 
 - 131-9 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article 
<br/><br/><label>ISSN: </label>1205-7541 
<br/><br/><label>Standard No.: </label>10.1139/y11-115  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Alprostadil--pharmacology<br/>Angioplasty, Balloon<br/>Animals<br/>Anti-Inflammatory Agents--pharmacology<br/>Aorta, Abdominal--drug effects<br/>Aortic Diseases--drug therapy<br/>Atherosclerosis--drug therapy<br/>Cardiovascular Agents--pharmacology<br/>Chemokine CCL2--genetics<br/>Cholesterol, Dietary<br/>Cytokines--metabolism<br/>Disease Models, Animal<br/>Disease Progression<br/>Dose-Response Relationship, Drug<br/>Down-Regulation<br/>Fibrosis<br/>Histamine<br/>Hydroxymethylglutaryl-CoA Reductase Inhibitors--pharmacology<br/>Inflammation Mediators--metabolism<br/>Lipid Metabolism--drug effects<br/>Macrophages--drug effects<br/>Male<br/>Matrix Metalloproteinase 1--genetics<br/>Matrix Metalloproteinase 9--genetics<br/>Plaque, Atherosclerotic--drug therapy<br/>RNA, Messenger--metabolism<br/>Rabbits<br/>Daboia<br/>Simvastatin--pharmacology<br/>Viper Venoms